Trivant Custom Portfolio Group, LLC Abbott Laboratories Transaction History
Trivant Custom Portfolio Group, LLC
- $195 Billion
- Q3 2025
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 14,805 shares of ABT stock, worth $1.93 Million. This represents 1.02% of its overall portfolio holdings.
Number of Shares
14,805
Previous 14,621
1.26%
Holding current value
$1.93 Million
Previous $1.99 Billion
0.28%
% of portfolio
1.02%
Previous 1.09%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,646Shares Held
1.38BCall Options Held
10.3MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...